Obsessive-Compulsive Disorder (OCD)
If You Are Struggling With:
* Stress and Tension
* Feeling Helpless or Hopeless
* Other Emotional Problems
Recovery International can help you to help yourself!
Nancy Keuthen, PhD
Co-Director, Trichotillomania Clinic and Research Unit
Chief Psychologist, Obsessive-Compulsive Disorder Clinic
Massachusetts General Hospital
Associate Professor of Psychology
Harvard Medical School
Understanding New Research and Treatment
When anxiety takes over, it interferes with your child’s ability to cope with fear, worry, and depression — and treatment is necessary.
Early intervention is critical. Waiting for your child to mature or grow out of these behaviors may not be the right approach. In some cases children may develop chronic anxiety and depression, which is often associated with substance abuse and other high-risk behaviors.
Martin Franklin, PhD
Associate Professor of clinical psychology in psychiatry
University of Pennsylvania School of Medicine
Dr. Franklin discusses treatment for children with trichotillomania, Tourette Syndrome, and other body-focused repetitive disorders and their relationship to anxiety disorders.Listen
Potential Adjunctive Treatment for OCD Patients who do not Adequately Respond to Treatment with a Serotonin Reuptake Inhibitor
Need more help for your OCD? Many people with OCD experience only a partial response to currently available medications.
Emory University and multiple sites across the U.S. are seeking volunteers to participate in a clinical trial evaluating the effectiveness of low-dose ondansetron augmentation for the treatment of OCD in patients who have not adequately responded to their current SRI therapy after at least 12 weeks of stable treatment.
Participants must have a DSM-IV-TR diagnosis of OCD as their primary disorder who have been on a stable treatment regimen of clomipramine, fluvoxamine, fluoxetine, paroxetine, or sertraline for at least 6 weeks may be eligible for this study. Six additional weeks of stable SRI treatment, without adequate clinical response, will be required prior to randomization, after which the participant will receive SRI plus study drug, for a total of 12 more weeks.
Exclusion critera include, but are not restricted to the following:
- Failure to respond to more than 2 SRI treatments prior to current SRI
- Hoarding as primary OCD symptom
- Current or past medical history of schizophrenia or other psychotic disorders, schizotypal personality disorder, bipolar disorder, Tourette syndrome, autism or autistic spectrum disorders, eating disorders, PTSD
- Requiring active behavioral therapy
- History of drug addiction or drug, alcohol, or other substance abuse within the past 12 months
- Currently taking, or having taken within the previous 8 weeks, any of the following: other SRIs, antipsychotic drugs, lithium, benzodiazepines or other anxiolytics, carbamazepine, oxcarbazepine, phenytoin, or other anti-depressants (including St. John's Wort)
- Likely to use triptans at any time during the study
- Belived to have suicidal or homocidal risk
This study is investigating what, if any, changes in brain chemistry take place in adults with OCD as a result of cognitive behavioral therapy (CBT). We will measure amounts and distribution of glutamate in the brain using MRSI (Magnetic Resonance Spectroscopic Imaging) scans before and after 4 weeks of CBT.
The study offers:
- Have no history of bipolar disorder, a psychotic disorder, or substance dependence
- Are in good physical health
- Have not already had more than 30 hrs of CBT for OCD
- Are right-handed
- Between the ages of 18 and 65
- Either not taking psychiatric medications or on a stable dose of a serotonin reuptake inhibitor (only) for at least 12 weeks
Listen to this podcast to find out about CBT, or cognitive-behavioral therapy, and how therapists use it to treat anxiety and related disorders.
Meets first Wednesday of each month; 7:00–8:30 pm